Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine.

× No keyword cloud information.

10 in total

Review 1. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors: Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal: World J Gastroenterol Date: 2017-09-28 Impact factor: 5.742

2. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Authors: D Macfarlane; J Gonin; D Wieland; T Mangner; J Froelich; W Beierwaltes; B Shapiro
Journal: Eur J Nucl Med Date: 1996-02

Review 3. Carcinoid-syndrome: recent advances, current status and controversies.

Authors: Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal: Curr Opin Endocrinol Diabetes Obes Date: 2018-02 Impact factor: 3.243

4. The influence of hypothalamically administered reserpine on the sexual behavior of the female cat.

Authors: V A Cerny
Journal: Psychopharmacology (Berl) Date: 1976-11-24 Impact factor: 4.530

Review 5. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin.

Authors: M Camilleri
Journal: Neurogastroenterol Motil Date: 2010-12-15 Impact factor: 3.598

6. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Authors: P Ruszniewski; M Ducreux; J A Chayvialle; J Blumberg; D Cloarec; H Michel; J M Raymond; J L Dupas; H Gouerou; R Jian; E Genestin; P Bernades; P Rougier
Journal: Gut Date: 1996-08 Impact factor: 23.059

Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine.

Review 1. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

2. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Review 3. Carcinoid-syndrome: recent advances, current status and controversies.

4. The influence of hypothalamically administered reserpine on the sexual behavior of the female cat.

Review 5. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin.

6. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Review 7. Sexual behavior of the male schizophrenic: the impact of illness and medications.

8. Tryptophan in the treatment of carcinoid crisis.

Review 9. Neurally mediated syncope and serotonin reuptake inhibitors.

10. Ethanol, monoamines, and affect.